<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> newly diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> in Kronoberg during 3 years was registered, with blood samples from 1630/1666 (97.8%) adults </plain></SENT>
<SENT sid="1" pm="."><plain>Those positive for GADab and/or ICA and/or C-<z:chebi fb="7" ids="16670">peptide</z:chebi>&lt;0.25nmol/L (0.7%) were classified as type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, the remaining as type 2 </plain></SENT>
<SENT sid="2" pm="."><plain>Incidence of type 1 in 0-19-year-olds was 37.8(36.1-39.6, 95%CI) and in 20-100 year-olds 27.1(25.6-27.4) per 100 000 and year, it was bimodal with equal peaks in 0-9 year-olds and in 50-80-year-olds </plain></SENT>
<SENT sid="3" pm="."><plain>Adults had type 2 incidence 378 (375-380), children 3.1 (2.6-3.6) </plain></SENT>
<SENT sid="4" pm="."><plain>Among adults 6.9% had type 1 and 93.1% type 2 </plain></SENT>
<SENT sid="5" pm="."><plain>Among antibodypositive adults (n=101), GADab were present in 90%, ICA in 71%, both GADab and ICA in 61% </plain></SENT>
<SENT sid="6" pm="."><plain>Ophthalmology contact as second source was confirmed for 98% </plain></SENT>
<SENT sid="7" pm="."><plain>There were no gender differences in type 1 in any age group, small ones in pediatric subgroups </plain></SENT>
<SENT sid="8" pm="."><plain>In type 2 men predominated in ages above 40 years </plain></SENT>
<SENT sid="9" pm="."><plain>Incidences of type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> in both children and adults were very high and as high above age 50 years as in children </plain></SENT>
<SENT sid="10" pm="."><plain>Incidence of type 2 was the highest reported from Sweden, to which new diagnostic criteria, a high degree of case-finding, and many elders, may have contributed, but results may also reflect a true increase in incidence of both types of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>